Table 2 Peritonitis outcomes at 18 months
HIV-Negative | HIV-Positive | P value | |
|---|---|---|---|
Peritonitis episodes, n (n excluding relapse)a | 54 (49) | 94 (81) | 0.001b |
Participants with a peritonitis episode at 180 dayse | 24.3% (17/70) | 51.4% (36/70) | 0.001 |
Participants with a peritonitis episode at 1 yeare | 38.6% (27/70) | 60.0% (42/70) | 0.011 |
Participants with a peritonitis episode at 18 monthse | 44.3% (31/70) | 65.7% (46/70) | 0.011 |
Multiple peritonitis episodes | |||
Time between peritonitis episodes (days), median (IQR) | 75 (39–107) | 55.5 (34.5–115.5) | 0.503d |
Relapse | 9.2% (5/54) | 13.8% (13/94) | 0.602c |
Recurrent | 3.7% (2/54) | 6.4% (6/94) | 0.711c |
Repeat (Same organism) | 11.1% (6/54) | 7.4% (7/94) | 0.448b |
Repeat (Different organism) | 18.5% (10/54) | 23.4% (22/94) | 0.487b |
Time - Tenckhoff catheter insertion to peritonitis episode | |||
Median, days (IQR) | 184.5 (98–370) | 144.5 (63–296) | 0.124d |
Within 180 days | 50.0% (27/54) | 56.4% (53/94) | 0.453b |
Between 180 – 365 days | 24.1% (13/54) | 27.7% (26/94) | 0.634b |
Between 365 – 550 days | 25.9% (14/54) | 16.0% (15/94) | 0.141b |
PD WCC (cells/μl), median (IQR) | 1073 (360–2690) | 979 (360–2370) | 0.927d |
Outpatient treatment | 33.3% (18/54) | 40.4% (38/94) | 0.392b |
Inpatient treatment | 66.7% (36/54) | 59.6% (56/94) | 0.392b |
Inpatient stay (days), median (IQR) | 9 (7–12) | 8 (7–14.5) | 0.574d |
Peritonitis episode outcomes | |||
CAPD continuation | 70.4% (38/54) | 78.7% (74/94) | 0.254b |
Catheter removal | 25.9% (14/54) | 17.0% (16/94) | 0.195b |
Mortality | 3.7% (2/54) | 4.3% (4/94) | 1.000c |